Monte Rosa Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 03 Jun 24 | SellUS$4,876 | Edmund Dunn | Individual | 1,207 | US$4.04 |
Insider Trading Volume
Insider Buying: GLUE insiders have only sold shares in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 522 | 0.000854% |
| Individual Insiders | 442,092 | 0.723% |
| Hedge Funds | 9,451,095 | 15.5% |
| General Public | 10,395,912 | 17% |
| VC/PE Firms | 16,589,351 | 27.1% |
| Institutions | 24,261,518 | 39.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.8%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 8,897,053 | US$34.6m | 0% | 12.02% | |||
| 7,692,298 | US$29.9m | 0% | 1.88% | |||
| 5,340,802 | US$20.8m | -3.55% | no data | |||
| 5,096,787 | US$19.8m | 3.15% | no data | |||
| 4,916,095 | US$19.1m | 0% | 0.22% | |||
| 4,535,000 | US$17.6m | 0% | 0.2% | |||
| 2,307,009 | US$9.0m | -2.74% | no data | |||
| 1,635,829 | US$6.4m | 2.98% | no data | |||
| 1,472,331 | US$5.7m | 0% | 2.39% | |||
| 1,464,015 | US$5.7m | 0% | 0.39% | |||
| 1,407,040 | US$5.5m | 0% | 0.56% | |||
| 980,239 | US$3.8m | -0.36% | no data | |||
| 735,533 | US$2.9m | 6.96% | no data | |||
| 615,251 | US$2.4m | 7.3% | no data | |||
| 510,882 | US$2.0m | 0% | 0.15% | |||
| 416,538 | US$1.6m | 0% | no data | |||
| 290,454 | US$1.1m | 1.94% | no data | |||
| 265,278 | US$1.0m | 15.4% | 0.01% | |||
| 250,582 | US$974.8k | 2.04% | no data | |||
| 193,168 | US$751.4k | 0% | no data | |||
| 150,025 | US$583.6k | 123% | no data | |||
| 122,100 | US$475.0k | 16.1% | no data | |||
| 120,647 | US$469.3k | 0% | no data | |||
| 103,087 | US$401.0k | -1.39% | no data | |||
| 94,019 | US$365.7k | -6.46% | no data |